Universiteit Leiden

nl en

Jan van der Laan

Assistant professor / guest

Dr. J.W. van der Laan
+31 6 5275 6424

Dr. Jan-Willem van der Laan is senior staff member (SOR-RIVM) at the Division of Drug Discovery & Safety.

More information about Jan van der Laan

van der Laan, Jan Willem, PhD

In 1980 Jan Willem van der Laan joined the National Institute for Public Health and the Environment (RIVM, Bilthoven) as a biochemist and pharmacologist on CNS targets. In 1990 he became assessor Pharmacology and Toxicology of Human Pharmaceuticals at the same institute. Since 2011 he serves in the same role the Medicines Evaluation Board, located in Utrecht, the Netherlands. He is chair of the EMA/CHMP Safety Working Party since 2012. His contributions to the International Council on Harmonization started in 1993 on Carcinogenicity Testing. In 2012 the discussions on this topic have been restarted to reduce the number of 2-yr studies in rodents, and Jan Willem is Regulatory Chair on this process.

Jan Willem van der Laan is leading a project on “Mechanistic differentiation of nongenotoxic carcinogenic pharmaceuticals and their human relevance”, funded by the Medicines Evaluation Board, on which project Britt Duijndam is working as a Ph.D student.


  • Pro-mitogenic effects of insulin analogues and mammary gland tumor development


  • Caput: "Regulation of Drug Safety (RDS)"

Assistant professor / guest

  • Science
  • Leiden Academic Centre for Drug Research
  • LACDR/Toxicology

Work address

Gorlaeus Building
Einsteinweg 55
2333 CC Leiden
Room number EM2.24



  • No relevant ancillary activities
This website uses cookies.  More information.